Korro Bio
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2015-01-01
- Employees
- 102
- Market Cap
- -
- Website
- http://www.frequencytx.com
- Introduction
Frequency Exchange Corp is focused on the development and global commercialization of a wearable Frequency Delivery System providing specialized programs designed for health and wellness as well as performance enhancement.
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Korro Bio, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT06677307
- Locations
- 🇳🇿
New Zealand Clinical Research, Christchurch, New Zealand
🇦🇺Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
News
No news found